Human Leukocyte Antigen Typing Using a Knowledge Base Coupled with a High-Throughput Oligonucleotide Probe Array Analysis

Human leukocyte antigens (HLA) are important biomarkers because multiple diseases, drug toxicity, and vaccine responses reveal strong HLA associations. Current clinical HLA typing is an elimination process requiring serial testing. We present an alternative in situ synthesized DNA-based microarray method that contains hundreds of thousands of probes representing a complete overlapping set covering 1,610 clinically relevant HLA class I alleles accompanied by computational tools for assigning HLA type to 4-digit resolution. Our proof-of-concept experiment included 21 blood samples, 18 cell lines, and multiple controls. The method is accurate, robust, and amenable to automation. Typing errors were restricted to homozygous samples or those with very closely related alleles from the same locus, but readily resolved by targeted DNA sequencing validation of flagged samples. High-throughput HLA typing technologies that are effective, yet inexpensive, can be used to analyze the world’s populations, benefiting both global public health and personalized health care.

[1]  Loren Gragert,et al.  Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. , 2013, Human immunology.

[2]  J. Klein,et al.  Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. , 2013, Blood.

[3]  Tze Hau Lam,et al.  Population-specific recombination sites within the human MHC region , 2013, Heredity.

[4]  H. Inoko,et al.  Detection of Ancestry Informative HLA Alleles Confirms the Admixed Origins of Japanese Population , 2013, PloS one.

[5]  J. Castle,et al.  HLA typing from RNA-Seq sequence reads , 2012, Genome Medicine.

[6]  Vladimir Brusic,et al.  Ultra-high resolution HLA genotyping and allele discovery by highly multiplexed cDNA amplicon pyrosequencing , 2012, BMC Genomics.

[7]  Brent R Logan,et al.  A perspective on the selection of unrelated donors and cord blood units for transplantation. , 2012, Blood.

[8]  J. McCluskey,et al.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire , 2012, Nature.

[9]  S. Krishnakumar,et al.  High-throughput, high-fidelity HLA genotyping with deep sequencing , 2012, Proceedings of the National Academy of Sciences.

[10]  Martin Maiers,et al.  Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[11]  R. Vierkant,et al.  Consistency of HLA associations between two independent measles vaccine cohorts: a replication study. , 2012, Vaccine.

[12]  S. Natsugoe,et al.  Clinical implication of HLA class I expression in breast cancer , 2011, BMC Cancer.

[13]  P. Dunn,et al.  Sequencing-Based HLA Typing Using RNA , 2011 .

[14]  M. Daly,et al.  Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. , 2011, Gastroenterology.

[15]  Ayşe Albayrak,et al.  Role of HLA Allele Polymorphism in Chronic Hepatitis B Virus Infection and HBV Vaccine Sensitivity in Patients from Eastern Turkey , 2011, Biochemical Genetics.

[16]  Michael R. Johnson,et al.  HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. , 2011, The New England journal of medicine.

[17]  C. Sotozono,et al.  HLA‐B*1511 is a risk factor for carbamazepine‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis in Japanese patients , 2010, Epilepsia.

[18]  Hye‐Ryun Kang,et al.  HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. , 2010, Pharmacogenomics.

[19]  M. Pirmohamed,et al.  Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future. , 2010, Pharmacogenomics.

[20]  R. Hui,et al.  Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. , 2010, Pharmacogenomics.

[21]  M. Muramatsu,et al.  HLA Class I markers in Japanese patients with carbamazepine‐induced cutaneous adverse reactions , 2010, Epilepsia.

[22]  E. Thiel,et al.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. , 2009, The New England journal of medicine.

[23]  Yuriy Fofanov,et al.  Ultraspecific probes for high throughput HLA typing , 2009, BMC Genomics.

[24]  Sheau-Fang Yang,et al.  Oxcarbazepine‐induced Stevens‐Johnson Syndrome: A Case Report , 2009, The Kaohsiung journal of medical sciences.

[25]  K. Suphapeetiporn,et al.  Carbamazepine and phenytoin induced Stevens‐Johnson syndrome is associated with HLA‐B*1502 allele in Thai population , 2008, Epilepsia.

[26]  James Robinson,et al.  The IMGT/HLA database , 2008, Nucleic Acids Res..

[27]  S. Spellman,et al.  National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[28]  Steven J Mack,et al.  Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. , 2008, Human immunology.

[29]  L. Naldi,et al.  A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs , 2008, Pharmacogenetics and genomics.

[30]  Harriet Noreen,et al.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. , 2007, Blood.

[31]  I. Cascorbi,et al.  Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens , 2007, The Pharmacogenomics Journal.

[32]  Loren Gragert,et al.  High-resolution HLA alleles and haplotypes in the United States population. , 2007, Human immunology.

[33]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[34]  P. Kwan,et al.  Association between HLA‐B*1502 Allele and Antiepileptic Drug‐Induced Cutaneous Reactions in Han Chinese , 2007, Epilepsia.

[35]  Warren A. Kibbe,et al.  The issue of amalgams. , 1996, Nucleic Acids Res..

[36]  V. McKusick.  Mendelian Inheritance in Man and Its Online Version, OMIM , 2007, The American Journal of Human Genetics.

[37]  M. Khoury,et al.  Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. , 2006, American journal of epidemiology.

[38]  Munir Pirmohamed,et al.  Genetic factors in the predisposition to drug-induced hypersensitivity reactions , 2006, The AAPS Journal.

[39]  M. Schumacher,et al.  A marker for Stevens-Johnson syndrome …: ethnicity matters , 2006, The Pharmacogenomics Journal.

[40]  G. Ferrara,et al.  Single nucleotide polymorphisms detection based on DNA microarray technology: HLA as a model. , 2005, Autoimmunity reviews.

[41]  Jerzy K. Kulski,et al.  High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR–SSOP–Luminex method in the Japanese population , 2005, Immunogenetics.

[42]  F. Balloux,et al.  Pathogen-Driven Selection and Worldwide HLA Class I Diversity , 2005, Current Biology.

[43]  Jürgen Neppert,et al.  Re: Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel , 2005, Transfusion.

[44]  Robertson Davenport,et al.  Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel , 2004, Transfusion.

[45]  Yuan-Tsong Chen,et al.  A marker for Stevens–Johnson syndrome , 2004 .

[46]  A. Falus,et al.  DNA Typing Revealing High HLA-Cw Polymorphism Completes Availability of Major Histocompatibility Complex Loci in Forensic Medicine , 2003, The American journal of forensic medicine and pathology.

[47]  B. Charlesworth,et al.  Biological and biomedical implications of the co-evolution of pathogens and their hosts , 2002, Nature Genetics.

[48]  Clive E. Bowman,et al.  Genetic variations in HLA-B region and hypersensitivity reactions to abacavir , 2002, The Lancet.

[49]  C. Moore,et al.  Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir , 2002, The Lancet.

[50]  P. Gasparini,et al.  Fixed drug eruptions with feprazone are linked to HLA-B22. , 1997, Journal of the American Academy of Dermatology.

[51]  A. Toubert,et al.  Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. , 1996, The Journal of clinical investigation.

[52]  J. Roujeau,et al.  Genetic susceptibility to toxic epidermal necrolysis. , 1987, Archives of dermatology.

[53]  C. Griscelli,et al.  Prenatal testing for inherited immune deficiencies by fetal blood sampling , 1982, Prenatal diagnosis.

[54]  G. Panayi,et al.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. , 1978, British medical journal.

[55]  E. Witebsky.  Histocompatibility Testing, 1967 , 1969 .

[56]  Lyal B. Harris.  November , 1890, The Hospital.

[57]  Jerzy K. Kulski,et al.  The HLA genomic loci map: expression, interaction, diversity and disease , 2009, Journal of Human Genetics.

[58]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[59]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[60]  Cristina Battaglia,et al.  Detection of HLA polymorphisms by ligase detection reaction and a universal array format: a pilot study for low resolution genotyping. , 2003, Human immunology.

[61]  Z. Guo,et al.  Oligonucleotide arrays for high resolution HLA typing. , 1999, Reviews in immunogenetics.

[62]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[63]  W. A. Zellmer.  Toward understanding. , 1988, American journal of hospital pharmacy.

[64]  Yusuke Nakamura,et al.  Genome-wide association study identifies HLA-A ∗ 3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population , 2022 .